Beta^6^-N-acetylglucosaminyltransferase
RxNorm 46981
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 46981 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Beta^6^-N-acetylglucosaminyltransferase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Beta-1,3-galactosyl-o-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase
(Atom ID: 10797915)
FN
Full form of descriptor (FN):
Beta-1,3-galactosyl-o-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (substance)
(Atom ID: 10797916)
SY
Synonym (SY):
Beta^6^-N-acetylglucosaminyltransferase
(Atom ID: 10798025)
SY